News

Exercise improves symptoms by changing the way the brain works

Date

Scottish Medicines Consortium (SMC) approves Opicapone for use in NHS Scotland

Date

Looking after yourself and keeping active this new year

Date

Ymddiriedolwr Newydd ar gyfer Cymru - New Trustee for Wales

Date

Mae’n bleser gan Parkinson’s UK Cymru groesawu ymddiriedolwr newydd, Elaine Evans.

Parkinson’s UK Cymru are delighted to welcome their new trustee, Elaine Evans.

We've launched a funding programme for studies into non-drug treatments for Parkinson’s

Date

Parkinson’s UK is launching a new funding programme to support innovative studies into non-drug treatments for Parkinson’s.
Researcher, Steve Gentleman, holds up a slide showing brain tissue

Survey shows a lack of awareness of brain donation for research

Date

Our survey of 2,000 UK adults shows that research is at risk due to a lack of awareness surrounding brain donation.

What the latest budget means for people with Parkinson's

Date

We provide a summary of what the latest budget means for people with Parkinson's, their carers and families 

Over 150 nurses in Northern Ireland hear about the Excellence Network

Date

Nuala Campbell, our Education Adviser, presented to more than 150 nurses promoting our work and specifically the Excellence Network.

Cannabis extract may hold key to stop pain in Parkinson's

Date

Cannabis-based compounds could be the silver bullet to relieve pain for people with Parkinson’s according to the largest ever study into pain and the condition.

Cymru yn cynnal cyfarfod cyntaf y Rhwydwaith Rhagoriaeth ar draws y wlad

Date

Daeth 80 o weithwyr proffesiynol ym maes iechyd a gofal cymdeithasol a phobl sydd wedi eu heffeithio gan glefyd Parkinson ynghyd yng Nghaerdydd ar 23 Ionawr ar gyfer cyfarfod cyntaf o Rwydwaith Rhagoriaeth Cymru Gyfan.

80 health and social care professionals and people affected by Parkinson’s came together in Cardiff on January 23 for the first All Wales Excellence Network meeting.

Potential treatment for dyskinesia in Parkinson’s

Date

Results from a one-year project, funded through the Parkinson’s Virtual Biotech, suggest that NLX-112 has potential as a future treatment for reducing dyskinesia and improving movement symptoms of Parkinson’s.

Sinemet availability

Date

The latest news on the Sinemet supply.

Initial results from CDNF clinical trial announced

Date

Herantis Pharma has published initial results from a phase 1/2 study of an experimental protective protein called CDNF which may hold potential to slow, stop or reverse Parkinson's.